Screener
TherapeuticsMD TXMD Q4 2025 Annual earnings
Reported March 30, 2026 · Before market open
Revenue$893.0KMiss by $18.9M
EPS-$0.05Beat by $6.07
Revenue estimate$19.8M
EPS estimate-$6.13
Next report
Nov 17, 2026 (in 3 months)Revenue estimate$19.8M
EPS estimate-$6.13
Versus estimates
Revenue
Q2 2026$869.0KMiss by $18.9MQ1 2026$724.0KMiss by $19.0M
Q4 2025$893.0KMiss by $18.9M
Q3 2025$784.0KQ2 2025$952.0KQ1 2025$393.0KDiluted EPS
Q2 2026$0.01Beat by $6.14Q1 2026$0.01Beat by $6.14
Q4 2025-$0.05Beat by $6.07
Q3 2025$0.01Q2 2025$0.05Q1 2025-$0.06FAQ
- When did TherapeuticsMD report Q4 2025 earnings?
- TherapeuticsMD (TXMD) reported Q4 2025 earnings on March 30, 2026 before market open.
- What were TherapeuticsMD's Q4 2025 revenue and EPS?
- TherapeuticsMD reported revenue of $893.0K and eps of $-0.05 for Q4 2025.
- Did TherapeuticsMD beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $19.8M by $18.9M. EPS beat the consensus estimate of $-6.13 by $6.07.
- How did TherapeuticsMD's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 33.9% from $667.0K a year earlier.
- Where can I find TherapeuticsMD's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-26-036519) and the 10-K periodic report (0001213900-26-036515) directly on SEC EDGAR. The filing index links above go to sec.gov.
